- Report
- November 2023
- 95 Pages
Europe
From €3089EUR$3,450USD£2,689GBP
- Report
- November 2023
- 93 Pages
Global
From €2642EUR$2,950USD£2,299GBP
- Report
- November 2023
- 173 Pages
Global
From €4432EUR$4,950USD£3,858GBP
- Report
- November 2024
- 108 Pages
Global
From €3500EUR$4,187USD£3,153GBP
- Report
- February 2024
- 78 Pages
Global
From €3500EUR$4,187USD£3,153GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,187USD£3,153GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£740GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£740GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£740GBP
- Report
- March 2024
- 132 Pages
Global
From €851EUR$950USD£740GBP
- Book
- October 2010
- 408 Pages
- Book
- March 2015
- 512 Pages
- Book
- October 2019
China
The Vasodilator market is a segment of the Medical Devices industry that focuses on the development and sale of products used to widen blood vessels. These products are used to treat a variety of conditions, including hypertension, coronary artery disease, and peripheral vascular disease. Vasodilators are typically administered through injection, infusion, or inhalation, and can be used to reduce blood pressure, improve blood flow, and reduce the risk of stroke and heart attack.
The Vasodilator market is highly competitive, with a number of large and small companies offering a variety of products. Major players in the market include Pfizer, Merck, Novartis, and Sanofi, while smaller companies such as Bausch Health, Mylan, and Teva Pharmaceuticals also offer products. Additionally, many generic drug manufacturers produce generic versions of popular vasodilators. Show Less Read more